EFSA’s Scientific Committee has launched an open consultation on a draft update of its guidance on the use of the benchmark dose (BMD) approach in risk assessment. This update confirms that the BMD approach is a scientifically more advanced method compared to the NOAEL approach for deriving a Reference Point (RP), and therefore recommends that the BMD approach, and more specifically model averaging, is used for deriving a Reference Point from the critical dose-response data to establish health-based guidance values and margins of exposure.
Deadline: 20 September 2016
Website: http://www.efsa.europa.eu/